The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2022 | The importance of obtaining real-world data
Doris Hansen
• 4 Jun 2022
Doris K. Hansen, MD, Moffitt Cancer Center, Tampa, FL, discusses the importance of obtaining real-world data and highlights the efficacy of idecabtagene vicleucel in a real-world setting. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.
